Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ADXN | US
0.05
0.47%
Healthcare
Biotechnology
30/06/2024
17/10/2024
10.60
10.46
10.60
10.44
Addex Therapeutics Ltd a development-stage biopharmaceutical company discovers develops and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for pain anxiety and addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc.; Indivior PLC; and The Charcot"Marie""Tooth Association. The company was formerly known as Addex Pharmaceuticals Ltd. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva Switzerland."
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
55.5%1 month
67.5%3 months
121.4%6 months
123.4%-
-
0.75
0.00
0.00
-0.76
6.29
-
-11.07M
11.33M
11.33M
-
-780.14
-
-81.80
-126.29
0.27
1.15
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
1.64
Range1M
1.91
Range3M
6.07
Rel. volume
0.36
Price X volume
91.20K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
KTRA | KTRA | Biotechnology | 0.2154 | 11.99M | -6.31% | n/a | 0.00% |
DOMH | DOMH | Biotechnology | 1.88 | 11.80M | -3.09% | n/a | 7.66% |
BioRestorative Therapies Inc | BRTX | Biotechnology | 1.6815 | 11.64M | -2.80% | n/a | 0.77% |
Jaguar Health Inc | JAGX | Biotechnology | 1.23 | 11.37M | 0.00% | 0.26 | 176.14% |
Immuron Limited | IMRN | Biotechnology | 1.97 | 11.22M | -1.99% | n/a | 1.37% |
Evogene Ltd | EVGN | Biotechnology | 2.14 | 11.15M | -16.08% | n/a | 26.41% |
TransCode Therapeutics Inc. Common Stock | RNAZ | Biotechnology | 0.599 | 10.78M | -11.79% | 0.00 | 17.19% |
Sensei Biotherapeutics Inc | SNSE | Biotechnology | 0.4237 | 10.66M | -7.69% | n/a | 9.67% |
RedHill Biopharma Ltd | RDHL | Biotechnology | 8.205 | 10.51M | -3.36% | n/a | 65.80% |
Alterity Therapeutics Limited | ATHE | Biotechnology | 1.2 | 10.49M | -4.00% | n/a | 1.15% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5763 | 8.36M | -11.91% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2111 | 3.79M | 2.93% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.04 | 2.71M | -4.59% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0114 | 1.02M | 14.00% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.16 | 0 | -0.43% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.3 | 0 | 2.14% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.535 | 0 | 7.00% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.07 | 0 | 1.90% | n/a | |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 14.54 | 0 | -1.56% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.76 | 0.53 | Cheaper |
Ent. to Revenue | 6.29 | 4,005.99 | Cheaper |
PE Ratio | - | 40.42 | - |
Price to Book | 0.75 | 15.30 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 121.38 | 72.92 | Riskier |
Debt to Equity | 0.00 | -1.24 | Expensive |
Debt to Assets | 0.00 | 0.25 | Cheaper |
Market Cap | 11.33M | 3.78B | Emerging |